SCHEMBL5960559

SCHEMBL5960559

Cc1ccc(-c2nnn(C)c2COc2ccc(C(=O)NC(C)C)cn2)nc1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 19/20 0.52
GABRA1 P14867 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2687635 0.90 GABRA5 (0.54) GABRA5
SCHEMBL10193063 0.88 GABRA5 (0.62) GABRA5GABRA1
SCHEMBL2689395 0.86 GABRA5 (0.64) GABRA5
SCHEMBL2687714 0.83 GABRA5 (0.62) GABRA5
SCHEMBL5959767 0.83 CYP2D6 (0.46) GABRA5GABRA1
SCHEMBL2688087 0.82 GABRA5 (0.63) GABRA5
SCHEMBL5960542 0.81 ABCB11 (0.40) GABRA5
SCHEMBL2688333 0.80 GABRA5 (0.63) GABRA5GABRA1
SCHEMBL2688356 0.77 GABRA5 (0.61) GABRA5
SCHEMBL2688726 0.76 GABRA5 (0.60) GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012062687-A1 TRIAZOLE DERIVATIVES AND THEIR USE FOR NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2012-05-18 WO disclosed